>

CVS Health Price to Sales Ratio Trend from 2010 to 2020

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 40px;;'>CVS</div>
CVS -- USA Stock  

Fiscal Quarter End: March 31, 2020  

CVS Health Price to Sales Ratio yearly trend continues to be relatively stable with very little volatility. Price to Sales Ratio is likely to grow to 0.40 this year. During the period from 2010 to 2020, CVS Health Price to Sales Ratio destribution of quarterly values had range of  0.45 from its regression line and mean deviation of  0.12. CVS Health Interest Expense is relatively stable at the moment as compared to the last year. CVS Health reported last year Interest Expense of 3.04 Billion. This year Income Tax Expense is likely to grow to about 2.7 B, while Direct Expenses is likely to drop slightly above 135.2 B. Check CVS Health fundamental indicators over time to gain insight into the future company performance. Apply historical fundamental analysis to find patterns among financial statement drivers such as Direct Expenses of 135.2 B, Consolidated Income of 6 B or Cost of Revenue of 182.9 B, as well as many exotic indicators such as Interest Coverage of 4.05, Long Term Debt to Equity of 1.09 or Calculated Tax Rate of 33.27. This can be a perfect complement to check CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Continue to the analysis of CVS Health Correlation with competitors.
Equity
Refresh

CVS Health Price to Sales Ratio Marginal Breakdown

Showing smoothed Price to Sales Ratio of CVS Health Corporation with missing and latest data points interpolated. Price to Sales Ratio is figured by comparing CVS Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CVS Health sales, a figure that is much harder to manipulate than other CVS Health Corporation multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. An alternative calculation method to [ps]; that measures the ratio between a company's adjusted share price and it's sales per share.
View

0.40 

          10 Years Trend
Decreasing
Slightly volatile
 Price to Sales Ratio 
    
  Timeline 

CVS Health Price to Sales Ratio Regression Statistics

Arithmetic Mean 0.52
Geometric Mean 0.50
Coefficient Of Variation 29.16
Mean Deviation 0.12
Median 0.48
Standard Deviation 0.15
Sample Variance 0.022721
Range 0.45
R-Value(0.45)
Mean Square Error 0.02024
R-Squared 0.20
Significance 0.17
Slope(0.020236)
Total Sum of Squares 0.23

CVS Health Price to Sales Ratio Over Time

2017  0.40 
2018  0.35 
2019  0.38 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

CVS Health Fundamental Drivers

CVS Health Corporation Fundamental Market Drivers

Short Percent Of Float1.44%
Forward Price Earnings8.95
Shares Short Prior Month20.25M
Average Daily Volume Last 10 Day5.65M
Average Daily Volume In Three Month6.45M
Date Short InterestJanuary 31, 2020
Fifty Day Average72.20
Two Hundred Day Average68.43

CVS Health Upcoming Events

CVS Health Upcoming Company Events

Upcoming Quarterly Earning ReportMay 6, 2020
Next Earnings ReportAugust 5, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 10, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019
Continue to the analysis of CVS Health Correlation with competitors. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.